Family Planning With Multiple Sclerosis: What to Know About Pregnancy Before, During, and After

For many people living with multiple sclerosis (MS), one of the first questions after diagnosis is whether they can still have a family. The answer is yes. MS does not make it harder to get pregnant, and labor and delivery outcomes match those of women without MS; however, pregnancy with MS goes best when it is planned.

The Corinne Goldsmith Dickinson Center for Multiple Sclerosis has launched a pregnancy planning program for people with MS. It was developed and is led by Anastasia (“Stacie”) Lyras, RN, a board certified Family Nurse Practitioner at the Center, where she provides compassionate, evidence-based care to people living with MS and other complex neurological conditions.

A member of the Center’s multidisciplinary Wellness Program, and she has a special interest in healthy lifestyle, mental health, and wellness in MS care. She serves as each patient’s main point of contact, working closely with the patient’s neurologist at every step of their pregnancy journey.

In this Q&A, she answers questions about the new program and what it means for patients planning a pregnancy.

Why is pregnancy planning so important for people with MS?

For some people, some MS treatments are not recommended during pregnancy, while other people may need a treatment-free interval before trying to conceive. Planning ahead means each patient has a clear, safe medication plan, and well-controlled MS before pregnancy begins. It is also a chance to address symptoms such as fatigue, spasticity (a stiffening of muscles), bladder problems, and mood changes. We also like to answer one of the common questions we receive from our patients: Will my child get MS? The reassuring answer is that most children born to parents with MS do not inherit the condition.

A photo of Anastasia (“Stacie”) Lyras, RN

Anastasia (“Stacie”) Lyras, RN

How are MS medications handled around pregnancy?

Our program follows an evidence-based approach; however, every plan is individualized. A growing body of evidence supports safely transitioning patients to a high-efficacy treatments before conception, and some of these therapies provide long-lasting coverage throughout pregnancy. The team also reviews symptom medications ahead of time. If a relapse does occur during pregnancy, safe treatment options are available.

Does MS affect fertility or treatments like in vitro fertilization (IVF)?

No. Ovulation, egg supply, and egg quality are normal, and MS does not cause miscarriage or birth defects. For patients who need fertility treatment, studies of women taking medications that help manage MS have found that IVF does not increase the risk of relapses. The MS team co-manages care with the patient’s fertility specialist.

How can patients prepare before trying to conceive?

Preparing for pregnancy with MS largely follows the same recommendations as for anyone else, and the program provides education on each aspect, including the use of folic acid, prenatal vitamins, vitamin D, and vaccines. If a patient’s DMT affects vaccine timing, the team coordinates with the patient’s obstetrician.

What should patients expect after delivery?

MS is often quieter during pregnancy, thanks to natural hormonal and immune changes. After delivery, those changes shift back, so the program sets up the plan to restart treatment before the baby arrives. Breastfeeding is encouraged, and in most cases, patients do not have to choose between breastfeeding and their MS treatment.

Why does the MS team ask about mood after delivery?

Mood changes are common for all new parents, and for those living with MS, these changes can be harder to recognize, since exhaustion, brain fog, and poor sleep can have many causes. Because the MS team knows each patient’s baseline, the team is well positioned to notice changes. The team checks in at every visit and connects patients directly with mental health care if needed.

What if a pregnancy is unplanned, or ends in a loss?

Unplanned pregnancies are common and can be managed well. Patients should not stop their medication on their own and should contact the MS team, who will guide next steps and bring them into the pregnancy planning program. MS does not raise the risk of miscarriage. If a loss does occur, the team supports the patient, restarts treatment promptly, and offers referral for counseling.

Why did the MS Center create a family planning program?

Routine obstetric visits rarely are long enough to discuss MS medications, possible complications during pregnancy, or breastfeeding and MS treatment. The Center’s family planning program gives patients dedicated time to discuss these questions and make a plan with their MS care team. The visits begin before pregnancy and continue into the postpartum period, just as routine obstetric care is ending. This allows the team to plan for changes in treatment and care, and to address questions about symptoms, mental health, medications, and breastfeeding. For many patients, these appointments may be the only visits where their MS and their pregnancy are discussed together. The program also supports patients with neuromyelitis optica spectrum disorder (NMOSD) with a plan tailored to their individual needs.

What happens at each visit?

The preconception visit reviews the patient’s MS history, stability, and MRIs, and maps out a medication plan for conception. It also covers symptom medications, a mental health check-in, and what to expect after delivery. The third-trimester visit gets ahead of the postpartum period. Treatment, labs, and MRIs for after delivery are ordered and scheduled in advance, and patients receive breastfeeding guidance with support from the Center’s registered dietitian, who is also a lactation specialist. The four-week postpartum check-in is designed to ensure the plan is on track and includes another mental health check-in.

What makes Mount Sinai’s program different?

The program offers patients one shared, evidence-based starting point for medication and timing guidance, tailored to each patient’s disease activity, treatment history, and goals. Most importantly, a plan is made before pregnancy, not after a medication has been stopped abruptly.

How do patients learn more about the MS Center’s new Family Planning Program?

To learn more about the program, patients can call the Center at 212-241-6854 or email Belenmarie Mixon, Administrative Coordinator, at Belenmarie.Mixon@mountsinai.org.

This article is for general education and is not a substitute for individual medical advice. Patients with MS who are thinking about pregnancy should talk with their MS care team before making any changes to their treatment.

 

How Is Multiple Sclerosis Diagnosed? An MS Expert Explains

Multiple sclerosis (MS) is an inflammatory disease in which the immune system attacks the central nervous system, damaging the myelin, the protective covering around certain nerves.

Over the last 20 years, multiple sclerosis has become a highly manageable disease. While there is no cure, new therapies can lessen the effects of MS and improve your quality of life, according to Mount Sinai’s Corinne Goldsmith Dickinson Center for Multiple Sclerosis.

In this Q&A, Ilana Katz Sand, MD, the Center’s Associate Director and Professor of Neurology at the Icahn School of Medicine at Mount Sinai, explains why it can be difficult to diagnose MS and what you can do if you are misdiagnosed.

How is multiple sclerosis diagnosed?

Unfortunately, there is no single diagnostic test for MS. Rather, an MS diagnosis is made by considering all available data and appropriately applying the diagnostic criteria. Clinicians review a patient’s medical history and symptoms, perform a neurological examination, and use magnetic resonance imaging, or MRI, to make a non-invasive scan of the brain and spinal cord. They will sometimes recommend a lumbar puncture (spinal tap) for additional information.

Other testing, such as examining the optic nerves, and blood tests to appropriately rule out other conditions, may also be performed. Any potential “red flags” to an MS diagnosis must be considered and the diagnostic criteria must then be carefully applied.

What are some overlapping symptoms between MS and other conditions?

What can sometimes make the diagnostic process difficult is that symptoms of MS can overlap with those of other conditions. For example, optic neuritis, an inflammation of the optic nerve that can cause pain and vision loss, is a common presenting symptom of MS. It is also a common presenting symptom of other inflammatory conditions such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disorder.

These conditions are also associated with lesions in the brain and spinal cord like MS. Other symptoms that are common in MS, such as fatigue and cognitive fogginess, are common in many other illnesses and are not specific to MS. Clinicians need to use clues from the way the symptoms present, the pattern of lesions on the MRI scan, blood and spinal fluid testing, and sometimes additional diagnostic tests to help differentiate MS from other conditions when it is not initially clear.

How common is it to misdiagnose MS?

Misdiagnosis of MS is not that uncommon. Research suggests that among referrals to medical centers that specialize in multiple sclerosis and offer advanced care, the rate of MS misdiagnosis may be as high as 20 percent. This is consistent with my personal experience over the years.

In my experience, misdiagnosis most commonly occurs when the clinician has not considered a diagnostic “red flag” carefully enough or has inappropriately applied the MS diagnostic criteria when a patient’s history, exam, or MRI findings are not typical for MS.

A change in clinical impression can also occur when new technology becomes available that causes the clinician to see things a different way. However, the numbers we see in research studies do not necessarily mean that one in five people who currently have an MS diagnosis have been misdiagnosed. Patients who are referred to advanced care centers tend to be more challenging cases, so this likely introduces some bias into this figure. The rate of misdiagnosis in the overall population is probably lower.

What should someone do if they have been misdiagnosed with MS but are still experiencing symptoms?

For someone who previously received an MS diagnosis but has since been told the diagnosis was not correct, the most important action is to understand why the clinician has changed their impression.

The next steps will be different depending on whether a new lab test result became available, clinical symptoms have changed (for example, there has been a lack of expected response to treatment), or the MRI scan has evolved in a way that was different than anticipated.

The clinical reasoning should drive next steps for further evaluation of the patient’s ongoing symptoms. The other action item I recommend is focusing on symptom management, taking a holistic view of care that incorporates optimizing things like nutrition, exercise and physical activity, and mental health. Attention to these parts of care can make a really big difference in the way a person feels regardless of their diagnosis.

Think You Know the Signs and Risks of a Stroke? Take the Quiz

A senior woman gazes out of a window with her husband, behind her, also gazing, as he holds her shoulder

Having a stroke is not inevitable. According to the American Heart Association and the American Stroke Association, approximately 80 percent of strokes can be prevented through lifestyle changes and managing important risk factors such as hypertension (high blood pressure) and diabetes over time.

How much do you know about strokes? Take the quiz below, then click “Done” to see your score and correct answers.

This quiz was developed with Carolyn Brockington, MD, Director of the Stroke Center at Mount Sinai West and Mount Sinai Morningside, and Associate Professor of Neurology at the Icahn School of Medicine at Mount Sinai.

Create your own user feedback survey

Worried About CTE? What to Know About Risk, Symptoms, and Diagnosis

A football player in a red helmet looks down the field at a fellow player, who is blurred in the background

You may have heard about chronic traumatic encephalopathy (CTE), a brain disease linked to repeated hits to the head. CTE has been found in some former NFL players and others who had repeated head impacts.

If you or a family member played contact sports, you may wonder about the risk of CTE. The risk depends in part on how often and for how long a person experienced repeated head impacts. Even people with extensive exposure do not always develop CTE.

In this Q&A, Kristen Dams-O’Connor, PhD, Director of the Brain Injury Research Center of Mount Sinai, explains what researchers know about CTE, what may affect your risk, and what you can do if you are concerned.

headshot of Kristen Dams-O’Connor, PhD, Director of the Brain Injury Research Center of Mount Sinai

Kristen Dams-O’Connor, PhD

How do I know if I’m at risk for CTE?

The biggest known risk factor for CTE is extensive exposure to repeated hits to the head over a long period of time. Researchers call these repetitive head impacts.

American football is the best-studied example. Repeated head impacts can also happen in other contact sports, including soccer, and possibly during military service or from domestic violence.

In football, the risk appears to increase based on how many years a person played, the level at which they played, and their position. For example, someone who played football briefly as a child or teenager would have a very different level of exposure than an NFL player who experienced repeated impacts for many years. If someone played in a position that exposed them to more impact, like a lineman, that may also carry greater risk.

Just because someone experiences repetitive head impacts does not mean they will get CTE. In fact, most people who have played football never develop CTE, and it isn’t clear yet why some do but others don’t.

Can one concussion cause CTE?

Current evidence does not suggest that one traumatic brain injury, whether it’s a mild concussion or more severe traumatic brain injury, puts you at significant risk for CTE. Researchers have found very few cases of CTE in people whose only known exposure was a single traumatic brain injury. The concern is greater when a person has repeated head impacts over time. These impacts do not have to cause diagnosed concussions, it is the extent and duration of repetitive head impacts that seems to matter most.

Can I be tested for CTE?

There is currently no test that can definitively diagnose CTE while a person is alive. CTE can only be diagnosed by examining brain tissue under a microscope after death.

Researchers are studying ways to diagnose CTE during life. These include blood tests that may detect signs of disease and specialized brain imaging. These tools are still being studied and cannot currently diagnose CTE in patients.

What symptoms should I be concerned about?

People who were found to have CTE after death have experienced symptoms such as:

  • memory changes
  • acting without thinking
  • irritability
  • trouble controlling emotions
  • poor decision-making
  • problems with planning, organizing, and completing tasks

Having these symptoms does not mean you have CTE. They are common after traumatic brain injuries and can also occur with dementia and many other conditions. At this time, researchers cannot tell from symptoms alone whether a person has the brain changes associated with CTE.

Substance use, including alcohol and drug use, can also contribute to symptoms during life, and may also contribute to the deaths of some people who are later diagnosed with CTE. But these concerns should not automatically be attributed to CTE, and many can be treated.

What can I do if I’m worried about CTE?

First, do not assume you have CTE. Problems such as memory difficulties, emotional changes, depression, or trouble controlling anger may have other causes, and some can be treated effectively. Also, fearing you have CTE may cause psychological problems. For example, research has found that some people who fear they have CTE experience depression and even suicidal thoughts and behaviors. Instead, focus on getting treatment for the symptoms you are experiencing rather than assuming CTE is causing them.

Behavioral and psychological treatments may help with some symptoms. For example, the Brain Injury Research Center of Mount Sinai offers neuropsychology and brain injury rehabilitation services that can help patients manage problems with thinking, memory, emotions, and behavior. Treatment may include psychotherapy, cognitive rehabilitation, and learning strategies for managing emotions. Medications may also be appropriate for certain symptoms.

What Are the Signs My Loved One Could Have Dementia?

An adult daughter sits with her senior father with her arm around his shoulder as they hold hands

As your loved one gets older, they may experience slower thinking, difficulty with names, and forgetfulness. But how can you tell the difference between normal age-related changes and those caused by dementia?

Dementia includes a range of disorders, including Alzheimer’s disease, the most common form of dementia, which is caused by abnormal protein deposits in the brain. While there are different types and causes of dementia, the symptoms are similar.

A headshot of Samuel Gandy, MD, PhD, Mount Sinai neurologist and prominent Alzheimer’s disease researcher

Samuel Gandy, MD, PhD

In this Q&A, Samuel Gandy, MD, PhD, a Mount Sinai neurologist and prominent Alzheimer’s disease researcher, explains common signs that your loved one may have dementia.

What signs could mean my loved one is developing dementia?

Possible signs of dementia include changes in memory and thinking that begin to interfere with a loved one’s everyday life. Changes that affect everyday activities may be noticed in a variety of ways.

For example, your loved one may:

  • Ask the same question repeatedly within a few minutes.
  • Forget to pay bills.
  • Become lost in familiar places.
  • Not recognize that anything has changed.

Why does my loved one not recognize these changes?

Not everyone who is developing dementia recognizes changes in memory or thinking. Some people notice changes in their own memory and decide to see a doctor. Others may not recognize that anything has changed. In those cases, family members or friends may be the first to notice problems, especially when changes begin to interfere with everyday life.

What factors may increase my loved one’s risk of dementia?

Several factors can make dementia more likely, especially if your loved one:

  • Is between the ages of 65 and 72. Alzheimer’s disease, the most common cause of dementia, typically occurs after age 65. Less common forms of Alzheimer’s disease and other types of dementia, such as frontotemporal dementia, can occur at younger ages.
  • Has a family history of dementia. If your loved one has a parent or sibling with dementia, their risk may be about twice as high as it would be otherwise.
  • Carries certain forms of a gene called APOE, which can substantially increase the risk of Alzheimer’s disease. Having two copies of certain forms of APOE can increase risk by as much as 12 times. Genetic testing for dementia is available at Mount Sinai.
  • Has experienced problems with blood flow to the brain, such as having a stroke. Multiple strokes are known to cause vascular dementia, a type of dementia associated with poor blood flow to the brain.
  • Has diabetes and/or is obese

What should I do if I think my loved one has dementia?

Don’t assume they have dementia. Speak to them gently. Tell them you have noticed they seem to have some trouble remembering things. Ask them if you can make an appointment with their primary care doctor and if it’s okay for you to go with them. In the meantime, take notes of what you are noticing to share with their doctor.

Pioneering Research Examines the Role of Your Gut in Multiple Sclerosis

Stephanie K Tankou, MD, PhD

Is a crucial cause of multiple sclerosis (MS) residing in your gut? Stephanie K Tankou, MD, PhD, Assistant Professor of Neurology at The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, is conducting research designed to prove that specific gut bacteria generate inflammation that underlies MS.

“At some point in our life, we can become exposed to various environmental stressors that can lead to profound changes in the gut microbe composition and put someone at risk for developing MS,” she says.

Trillions of microbes called the human microbiome are living in each human. The largest community of microbes, called the gut microbiome, exist in the gut. They are essential for the proper development of your immune system and your brain.

“Studies have shown that a disturbance in the normal composition of these gut microbes can lead to many diseases, including MS,” she says.

Within a healthy individual’s gut, there is a delicate balance of pro-inflammatory and anti-inflammatory bacteria. Conditions favoring an overgrowth of the pro-inflammatory bacteria can trigger inflammation in the gut leading to the breakdown of the gut barrier, also known as leaky gut. In individuals with a leaky gut, microbes in the gut can enter the bloodstream, where they will activate various immune cells, including inflammatory cells that will destroy myelin—a sheath that forms around nerves—in the brain and spinal cord of MS patients.

Several studies, including ones conducted at the Tankou Lab found that mice infused with gut microbes taken from MS patients develop more severe inflammation in the brain and spinal cord than mice that received gut microbes from healthy subjects.

“These results suggest that alterations found in the gut microbe composition of an MS patient significantly contributes to the disease,” she says. “So, the question is what changes do we need to introduce in the gut microbiome of MS patients to stop the disease?”

Dr. Tankou joined the Center staff in 2019. While she sees MS patients, she spends most of her time in her research lab.

“I became interested in the gut microbiome because one of the biggest hurdles we run into with MS, or any neurological disease, is we do not have access to the disease tissue, to the brain or the spinal cord,” she explains. “Consider the gut microbiome as a remote control for your brain. I can control the level of inflammation in the brain of my MS patients by changing the composition of their gut microbes.”

To further her theory, Dr. Tankou’s lab found that an antibiotic called vancomycin, when given orally to mice with an MS-like disease, suppresses inflammation in the brain and spinal cord. Her study showed that administering vancomycin orally causes significant changes in the mice gut microbe composition, leading to an increase in the abundance of anti-inflammatory bacteria in their gut, which decreased inflammation in the brain and spinal cord of these mice.

For her current, ongoing study, Dr. Tankou received funding from the Doris Duke Charitable Foundation to examine the impact of vancomycin on newly diagnosed MS patients between the ages of 18 and 50 who have not taken any MS treatment. Participants receive either vancomycin or a placebo as well as provide blood and stool samples.

“We are hopeful that vancomycin will cause a dramatic shift in the gut microbe composition of these MS patients that will suppress inflammation in the brain,” says Dr. Tankou. The findings from this vancomycin trial could lead to the development of the first “bugs as drugs” for the prevention and treatment of MS. “Bugs as drugs” refers to communities of gut derived bacteria with anti-inflammatory properties that can be used to suppress inflammation and disease progression in MS.

Dr. Tankou maintains that “bugs as drugs” will be safer than the current MS treatments approved by the Food and Drug Administration, which are all based on chemical structures and come with a range of side effects, whereas using microbes means nothing foreign will be introduced into patients. “We expect a new ‘bug as drugs’ therapy to be just as effective as drugs we are currently using,” she says.

The promise and hope that Dr. Tankou’s pioneering lab offers will position the Center as an institutional leader in understanding what causes MS, as well as developing novel microbiome-based therapies for preventing and treating all forms of the chronic disease.

By Kenneth Bandler, a multiple sclerosis patient, advocate, and member of The Corinne Goldsmith Dickinson Center for Multiple Sclerosis Advisory Board